The Nerve Growth Factor Receptor (NGFR/p75NTR): A Major Player in Alzheimer's Disease
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES(2023)
摘要
Alzheimer's disease (AD) represents the most prevalent type of dementia in elderly people, primarily characterized by brain accumulation of beta-amyloid (A beta) peptides, derived from Amyloid Precursor Protein (APP), in the extracellular space (amyloid plaques) and intracellular deposits of the hyperphosphorylated form of the protein tau (p-tau; tangles or neurofibrillary aggregates). The Nerve growth factor receptor (NGFR/p75(NTR)) represents a low-affinity receptor for all known mammalians neurotrophins (i.e., proNGF, NGF, BDNF, NT-3 e NT-4/5) and it is involved in pathways that determine both survival and death of neurons. Interestingly, also A beta peptides can blind to NGFR/p75(NTR) making it the "ideal" candidate in mediating A beta-induced neuropathology. In addition to pathogenesis and neuropathology, several data indicated that NGFR/p75(NTR) could play a key role in AD also from a genetic perspective. Other studies suggested that NGFR/p75(NTR) could represent a good diagnostic tool, as well as a promising therapeutic target for AD. Here, we comprehensively summarize and review the current experimental evidence on this topic.
更多查看译文
关键词
Alzheimer's disease,nerve growth factor receptor,NGFR,p75(NTR),amyloid-beta,expression,signaling pathways,neuropathology,diagnosis,treatment
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要